celecoxib has been researched along with Anxiety in 5 studies
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antidepressant-induced jitteriness/anxiety syndrome is characterized as anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, and (hypo)mania, which appear immediately after initiation or increased dosage of an antidepressant." | 5.91 | Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX-2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis. ( Kanno, M; Noto, K; Shirata, T; Suzuki, A; Yano, S, 2023) |
| "Antidepressant-induced jitteriness/anxiety syndrome is characterized as anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, and (hypo)mania, which appear immediately after initiation or increased dosage of an antidepressant." | 1.91 | Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX-2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis. ( Kanno, M; Noto, K; Shirata, T; Suzuki, A; Yano, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shirata, T | 1 |
| Yano, S | 1 |
| Noto, K | 1 |
| Kanno, M | 1 |
| Suzuki, A | 1 |
| Garabadu, D | 1 |
| Kumar, V | 1 |
| Blazeby, JM | 1 |
| Hall, E | 1 |
| Aaronson, NK | 1 |
| Lloyd, L | 1 |
| Waters, R | 1 |
| Kelly, JD | 1 |
| Fayers, P | 1 |
| Thomazeau, J | 1 |
| Rouquette, A | 1 |
| Martinez, V | 1 |
| Rabuel, C | 1 |
| Prince, N | 1 |
| Laplanche, JL | 1 |
| Nizard, R | 1 |
| Bergmann, JF | 1 |
| Perrot, S | 1 |
| Lloret-Linares, C | 1 |
| Iohom, G | 1 |
| Abdalla, H | 1 |
| O'Brien, J | 1 |
| Szarvas, S | 1 |
| Larney, V | 1 |
| Buckley, E | 1 |
| Butler, M | 1 |
| Shorten, GD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ambulatory Gynecologic Surgery: Finding the Optimal Postoperative Opioid Prescription[NCT03588910] | Phase 2 | 120 participants (Actual) | Interventional | 2018-08-08 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
By chart review, unscheduled interactions with the healthcare system related to pain will be counted.These will include phone calls related to pain, unscheduled visits to the office or emergency department (NCT03588910)
Timeframe: 1 week post operative
| Intervention | Unscheduled patient contacts (Number) |
|---|---|
| Number of Oxycodone Tablets Typically Prescribed | 1 |
| Half the Number of Oxycodone Tablets Typically Prescribed | 4 |
During the survey phone call on day 7, participants will be asked to report the total number of oxycodone tablets used since the surgery. (NCT03588910)
Timeframe: 7 days post-operative
| Intervention | Oxycodone Tablets (Median) |
|---|---|
| Number of Oxycodone Tablets Typically Prescribed | 2.5 |
| Half the Number of Oxycodone Tablets Typically Prescribed | 2.0 |
During the survey phone call on day 1, participants will be asked to report the total number of oxycodone tablets use since the surgery. (NCT03588910)
Timeframe: 24 hours post-operative
| Intervention | Oxycodone Tablets (Median) |
|---|---|
| Number of Oxycodone Tablets Typically Prescribed | 1.0 |
| Half the Number of Oxycodone Tablets Typically Prescribed | 1.0 |
Participants will be surveyed during the phone call survey to rate pain score on a scale from 0 (no pain), to 10 (severe pain) (NCT03588910)
Timeframe: 1 day post operative
| Intervention | Score on Numeric Pain Scale (Median) |
|---|---|
| Number of Oxycodone Tablets Typically Prescribed | 5.0 |
| Half the Number of Oxycodone Tablets Typically Prescribed | 5 |
Participants will be surveyed during the phone call survey to rate pain score on a scale from 0 (no pain), to 10 (severe pain) (NCT03588910)
Timeframe: 7 days post operative
| Intervention | Score on Numeric Pain Scale (Median) |
|---|---|
| Number of Oxycodone Tablets Typically Prescribed | 2.0 |
| Half the Number of Oxycodone Tablets Typically Prescribed | 1.3 |
2 trials available for celecoxib and Anxiety
| Article | Year |
|---|---|
Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Anxiety; Celecoxib; Combined Modality Therapy; Cyclooxygenase 2 Inhi | 2014 |
The associations between severity of early postoperative pain, chronic postsurgical pain and plasma concentration of stable nitric oxide products after breast surgery.
Topics: Acetaminophen; Adult; Aged; Analgesia; Anxiety; Breast Neoplasms; Bupivacaine; Celecoxib; Chronic Di | 2006 |
3 other studies available for celecoxib and Anxiety
| Article | Year |
|---|---|
Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX-2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis.
Topics: Antidepressive Agents; Anxiety; Celecoxib; Cyclooxygenase 2 Inhibitors; Escitalopram; Female; Humans | 2023 |
Celecoxib potentiates the antianxiety and anticompulsive-like activity of fluoxetine against chronic unpredictable mild stress in experimental animals.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Celecoxib; Compulsive Behavior; Disease Mod | 2019 |
Acute pain Factors predictive of post-operative pain and opioid requirement in multimodal analgesia following knee replacement.
Topics: Acute Pain; Aged; Amides; Analgesics; Analgesics, Opioid; Anesthetics, Local; Anxiety; Arthroplasty, | 2016 |